Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
Potassium Phosphates is an intravenous solution containing dibasic and monobasic potassium phosphate salts used to correct electrolyte and phosphate deficiencies in hospitalized patients. It is an essential nutritional supplement administered in clinical settings to restore critical mineral balance. The product works by directly replenishing depleted phosphate and potassium levels in patients unable to maintain adequate intake orally.
Peak lifecycle product with stable hospital-based demand suggests mature team focused on market maintenance rather than aggressive expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Potassium Phosphates offers stability in a niche hospital-focused market with minimal competitive disruption and strong patent protection through 2039. Career progression emphasizes hospital relationships, supply chain optimization, and institutional partnerships rather than rapid growth or competitive launches.
Worked on POTASSIUM PHOSPHATES at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo